Skip to main content
SpringerLink
Log in

Tinzaparin ongoing safety review inconclusive, says FDA

  • News item
  • Published:
Inpharma Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tinzaparin ongoing safety review inconclusive, says FDA. Inpharma Wkly. 1667, 20 (2008). https://doi.org/10.2165/00128413-200816670-00068

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-200816670-00068

Keywords

Search

Navigation